Teglutik
Riluzole · Liquid · Oral
Current shortage
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1) – Available (EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.), updated Sep 15, 2026)
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1) – Available (EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.), updated Sep 15, 2026)
Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1) – Available (EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.), updated Sep 15, 2026)
No FDA structured label text is available for Teglutik. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Riluzole in 3 products
Teglutik NDC products (3)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 70726-0305 | Riluzole 5 mg/mL Liquid | EDW PHARMA | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| 70726-0306 | Riluzole 5 mg/mL Liquid | EDW PHARMA | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| 70726-0304 | Riluzole 5 mg/mL Liquid | EDW PHARMA, INC | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
Frequently asked questions
Who makes Teglutik?
Teglutik is listed by 2 labelers in the FDA NDC directory, including EDW PHARMA, EDW PHARMA, INC.